4.4 Review

The use of wearable devices in chronic disease management to enhance adherence and improve telehealth outcomes: A systematic review and meta-analysis

Journal

JOURNAL OF TELEMEDICINE AND TELECARE
Volume 28, Issue 5, Pages 342-359

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1357633X20937573

Keywords

Wearable device; chronic obstructive pulmonary disease; diabetes; cardiac disease; systematic review; meta-analysis

Funding

  1. JSPS KAKENHI, Tokyo, Japan [19H01082]
  2. Grants-in-Aid for Scientific Research [19H01082] Funding Source: KAKEN

Ask authors/readers for more resources

Wearable device interventions are increasingly used in chronic disease management, but their effectiveness in improving telehealth outcomes has not been extensively discussed. This study evaluated the effects of wearable devices on adherence and other health outcomes for patients with chronic obstructive pulmonary disease, diabetes mellitus, and cardiac disease. The results suggest that wearable devices with educational support may be particularly beneficial for patients with diabetes mellitus and cardiac disease.
Introduction Wearable device (WD) interventions are rapidly growing in chronic disease management; nevertheless, the effectiveness of these technologies to monitor telehealth outcomes has not been adequately discussed. This study aims to evaluate the effects of WDs in adherence and other health outcomes for people with chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), and cardiac disease (CD). Methods CINAHL, PsycINFO, CENTRAL, and EMBASE were searched for randomized controlled trials (RCTs) and non-RCTs from 1937 to February 2020. Studies comparing interventions with the use of WD were assessed for quality in RCTs and a meta-analysis was performed. Results Eleven studies were included in this review. All of the interventions involved WD use with educational support such as goal setting, virtual social support, e-health program, real-time feedback, written information, maintain diary, and text messaging. The meta-analysis showed no difference in adherence (p = .38). The DM group showed effects of more than a 2% reduction in weight when WDs were implemented for three months (risk ratio = 2.20; 95% confidence interval (CI) 1.38 to 3.50;p = .0009), as well as blood glucose (mean difference (MD) = -32.39; 95% CI = -48.07 to -16.72;p < .0001), haemoglobin A(1c)(MD = -0.69; 95% CI = -1.28 to -0.10;p = .02), and physical exercise time in the CD group (MD = 9.53; 95% CI = 0.59 to 18.47;p = .04). Discussion WD with educational support may be particularly useful for people with DM and CD to enhance support beyond usual care. The results of this review showed insufficient evidence to support the use of WD for COPD to enhance telehealth outcomes for disease management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available